Cite
HARVARD Citation
Roberts, Z. et al. (2018). Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL. Leukemia & lymphoma. 59 (8), pp. 1785-1796. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Roberts, Z. et al. (2018). Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL. Leukemia & lymphoma. 59 (8), pp. 1785-1796. [Online].